Table 1.
Analysis of intracellular pools of pathway intermediates.
| Strain | Concentrations after 48 h (mg/L) | |||
|---|---|---|---|---|
| L-Phenylalanine | Cinnamic acid | p-Coumaric acid | Pinosylvin | |
| pCDFD-T7-RgPALa | 99 ± 3 | 249 ± 4 | 27 ± 0.4 | 0 |
| pCDFD-T7-TcPALb | 125 ± 3 | 465 ± 6 | 40 ± 0.3 | 0 |
| pCDFD-Trc-RgPAL-Trc-4CLc | 90 ± 2 | 200 ± 3 | 26 ± 0.3 | 3.7 ± 0.03 |
| pCDFD-Trc-TcPAL-Trc-4CLd | 116 ± 3 | 404 ± 6 | 36 ± 0.2 | 10.5 ± 0.11 |
aRgPAL was directly cloned into NcoI/AvrII sites of pCDFDuet-1. Engineered strains contained pCOLA-T7-aroFwt-T7-pheAfbr and pCDFD-T7-RgPAL.
bTcPAL was directly cloned into NcoI/AvrII sites of pCDFDuet-1. Engineered strains contained pCOLA-T7-aroFwt-T7-pheAfbr and pCDFD-T7-TcPAL.
cEngineered strains contained pCOLA-T7-aroFwt-T7-pheAfbr, pCDFD-Trc-RgPAL-Trc-4CL, pETD-T7-STS.
dEngineered strains contained pCOLA-T7-aroFwt-T7-pheAfbr, pCDFD-Trc-TcPAL-Trc-4CL, pETD-T7-STS.